Bleeding versus stent thrombosis: can short DAPT be safe in complex lesions?

Chairperson: Alexandre ABIZAID, Philip URBAN


To discuss changes in DAPT guidelines and their application in daily practice
To identify the patient populations that suffer from bleeding complications and cannot tolerate DAPT duration
To understand how selection of a polymer-free stent can support optimising treatment of patients


Session objectives

A. Abizaid

Evidence for optimal DAPT duration following stenting is inconclusive

A. Iniguez Romo

LIVE demonstration from Contilia Heart and Vascular Center - Essen, Germany

Are polymer-free drug-coated stents the solution for short DAPT?

T. Kinnaird

Clinical evidence on the horizon

G. Sardella

Session evaluation and key learnings

P. Urban

More from Biosensors

Visit website